Preclinical Safety Assessment and Pharmacovigilance
Course, Master's level, 3FX211
Spring 2024 Spring 2024, Flexible, 50%, Distance learning, English
- Location
- Flexible
- Pace of study
- 50%
- Teaching form
- Distance learning
- Number of mandatory on-campus meetings
- 0
- Number of optional on-campus meetings
- 0
- Instructional time
- Mixed
- Study period
- 15 January 2024–20 March 2024
- Language of instruction
- English
- Entry requirements
-
University education equivalent to at least 180 credits (i.e. three years of full-time studies) in pharmacy, pharmaceutical science, medical science, veterinary medical science, biomedicine, science or technology; previous studies should include biomedical courses such as pharmacology or toxicology. All applicants need to verify English language proficiency. This is normally verified by means of an internationally recognised test such as TOEFL or IELTS.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
-
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- Application fee: SEK 900
- First tuition fee instalment: SEK 18,125
- Total tuition fee: SEK 18,125
- Application deadline
- 16 October 2023
- Application code
- UU-88505
Admitted or on the waiting list?
Spring 2024 Spring 2024, Flexible, 50%, Distance learning, English For exchange students
- Location
- Flexible
- Pace of study
- 50%
- Teaching form
- Distance learning
- Number of mandatory on-campus meetings
- 0
- Number of optional on-campus meetings
- 0
- Instructional time
- Mixed
- Study period
- 15 January 2024–20 March 2024
- Language of instruction
- English
- Entry requirements
-
University education equivalent to at least 180 credits (i.e. three years of full-time studies) in pharmacy, pharmaceutical science, medical science, veterinary medical science, biomedicine, science or technology; previous studies should include biomedical courses such as pharmacology or toxicology. All applicants need to verify English language proficiency. This is normally verified by means of an internationally recognised test such as TOEFL or IELTS.
Admitted or on the waiting list?
About the course
This introductory course provides a concise overview of the principles of preclinical safety assessment and pharmacovigilance. We will discuss the assessment of drug candidates, risk/benefit profiling of drugs and the safe use of medicines. The course is suitable for those who want to work with preclinical toxicity testing or adverse drug reaction reporting and pharmacovigilance.
The course will focus on the principles of
- mechanisms of toxicity and adverse drug reactions
- preclinical toxicity testing
- phase 1 clinical trials
- drug recalls
- risk/benefit assessments of drug candidates and pharmaceutical drugs
- pharmacovigilance.
We will discuss the safety of drug candidates and pharmaceutical drugs based on toxicity testing, clinical trials as well as on general use on the market. The course will not cover the detailed regulatory toxicity testing and pharmacovigilance guidelines and regulations set up by medicine agencies such as EMA and FDA, or the web-based pharmacovigilance tools set up by these agencies. Furthermore, the course will not cover the detailed regulations for adverse event reporting within pharmaceutical companies.
Outline for distance course: The course is entirely web-based and contains no compulsory campus meetings. Lectures are recorded and organised as video/audio sessions and are available on a web-based teaching platform. The students are offered supervised studies via the same teaching platform. This platform is also used for individual assignments, group exercises and discussions. Some of these assignments and exercises are mandatory and the participants are offered general or individual feedback on these moments. The participants and teachers communicate via the website and via email. A forum for discussion is also available. Examination will be in the form of web-based tests or individual assignments. In order to participate in this course you must have access to a computer with internet connection and headset with microphone.
The course is given in collaboration with the Uppsala Monitoring Centre (UMC). UMC is responsible for the management of the WHO Programme for International Drug Monitoring and the WHO Global ICSR Database.